作者: Prinesh N Patel , Pradipbhai D Kalariya , S Gananadhamu , R Srinivas , None
DOI: 10.1016/J.JPBA.2015.07.028
关键词:
摘要: Fingolimod (FGL), an immunomodulator drug for treating multiple sclerosis, was subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolysis thermal stress, as per International Conference on Harmonization specified conditions. The showed extensive degradation under base hydrolysis, however, it stable all other A total of three products (DPs) were observed. chromatographic separation the its achieved a Fortis C18 (100×2.1mm, 1.7μm) column with mobile phase composed 0.1% formic acid (Solvent A) acetonitrile B) in gradient mode. All DPs identified characterized by liquid chromatography-quadrupole time flight-mass spectrometry (LC-Q-TOF-MS) combination accurate mass measurements. major DP isolated Nuclear Magnetic resonance spectroscopy. This is typical case where used co-solvent stress studies, reacts FGL hydrolytic conditions produce acetylated DPs. Hence, can be suggested that not preferable FGL. developed UHPLC method validated ICH guidelines.